Select Publications
Journal articles
2024, 'Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022', Clinical Rheumatology, 43, pp. 1823 - 1832, http://dx.doi.org/10.1007/s10067-024-06967-8
,2024, 'Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings', Internal Medicine Journal, 54, pp. 795 - 801, http://dx.doi.org/10.1111/imj.16296
,2024, 'Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis', Seminars in Arthritis and Rheumatism, 65, http://dx.doi.org/10.1016/j.semarthrit.2024.152383
,2024, 'The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region', Seminars in Arthritis and Rheumatism, 65, http://dx.doi.org/10.1016/j.semarthrit.2024.152384
,2023, 'Magnetic resonance imaging RAMRIS-SAFE score—A low-risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials', International Journal of Rheumatic Diseases, 26, pp. 1960 - 1966, http://dx.doi.org/10.1111/1756-185X.14847
,2023, 'RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference Measures', ACR Open Rheumatology, 5, pp. 511 - 521, http://dx.doi.org/10.1002/acr2.11574
,2023, 'Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’', Annals of the Rheumatic Diseases, 82, http://dx.doi.org/10.1136/annrheumdis-2022-222161
,2023, 'Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set', ACR Open Rheumatology, 5, pp. 345 - 353, http://dx.doi.org/10.1002/acr2.11577
,2023, 'Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia', JAMA Network Open, 6, pp. E2320851, http://dx.doi.org/10.1001/jamanetworkopen.2023.20851
,2023, 'Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults', New England Journal of Medicine, 388, pp. 595 - 608, http://dx.doi.org/10.1056/nejmoa2209604
,2023, 'Comparative validation of the knee inflammation MRI scoring system and the MRI osteoarthritis knee score for semi-quantitative assessment of bone marrow lesions and synovitis-effusion in osteoarthritis: an international multi-reader exercise', Therapeutic Advances in Musculoskeletal Disease, 15, http://dx.doi.org/10.1177/1759720X231171766
,2023, 'AB0249 RHEUMETRIC QUANTITATIVE 0-10 PHYSICIAN ESTIMATES OF INFLAMMATION, DAMAGE, AND DISTRESS IN RHEUMATOID ARTHRITIS: VALIDATION AGAINST REFERENCE MEASURES', Scientific Abstracts, pp. 1308.3 - 1309, http://dx.doi.org/10.1136/annrheumdis-2023-eular.4992
,2023, 'AB1112 DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET', Scientific Abstracts, pp. 1785.1 - 1785, http://dx.doi.org/10.1136/annrheumdis-2023-eular.3359
,2023, 'AB1179 VARIATION OF INTER-RATER RELIABILITY FOR BONE MARROW LESION SCORES IN DIFFERENT REGIONS OF THE KNEE: A STUDY USING KIMRISS', Scientific Abstracts, pp. 1819 - 1820, http://dx.doi.org/10.1136/annrheumdis-2023-eular.1238
,2022, 'Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial', Trials, 23, pp. 743, http://dx.doi.org/10.1186/s13063-022-06589-y
,2022, 'Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis', Rheumatology (United Kingdom), 61, pp. 4305 - 4313, http://dx.doi.org/10.1093/rheumatology/keac073
,2022, 'Computer-Assisted Image Analysis in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis', ACR Open Rheumatology, 4, pp. 721 - 734, http://dx.doi.org/10.1002/acr2.11450
,2022, 'Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients', Rheumatology (United Kingdom), 61, pp. 1035 - 1043, http://dx.doi.org/10.1093/rheumatology/keab449
,2022, 'Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis', Rheumatology and Therapy, 9, http://dx.doi.org/10.1007/s40744-021-00416-7
,2022, 'Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia', Clinical Rheumatology, 41, pp. 53 - 62, http://dx.doi.org/10.1007/s10067-021-05853-x
,2022, 'POS0072 CONSISTENT LONG-TERM GUSELKUMAB EFFICACY ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE PATIENT CHARACTERISTICS', Annals of the Rheumatic Diseases, 81, pp. 253 - 254, http://dx.doi.org/10.1136/annrheumdis-2022-eular.47
,2021, 'Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging', Seminars in Arthritis and Rheumatism, 51, pp. 1125 - 1133, http://dx.doi.org/10.1016/j.semarthrit.2021.08.004
,2021, 'Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: Post hoc analysis of FINCH 3', RMD Open, 7, pp. e001621, http://dx.doi.org/10.1136/rmdopen-2021-001621
,2021, 'Arthritis and enthesitis in the hip and pelvis region in spondyloarthritis - OMERACT validation of two whole-body MRI methods', Seminars in Arthritis and Rheumatism, 51, pp. 940 - 945, http://dx.doi.org/10.1016/j.semarthrit.2021.05.006
,2021, 'Joint and entheseal inflammation in the knee region in spondyloarthritis - reliability and responsiveness of two OMERACT whole-body MRI scores', Seminars in Arthritis and Rheumatism, 51, pp. 933 - 939, http://dx.doi.org/10.1016/j.semarthrit.2021.05.013
,2021, 'OP0149 RELIABILITY AND RESPONSIVENESS OF TWO OMERACT WHOLE-BODY MRI SCORES OF ENTHESEAL AND JOINT INFLAMMATION IN THE KNEE REGION IN SPONDYLOARTHRITIS', Annals of the Rheumatic Diseases, 80, pp. 89 - 90, http://dx.doi.org/10.1136/annrheumdis-2021-eular.755
,2021, 'OP0252 ARTHRITIS AND ENTHESITIS IN THE HIP AND PELVIS REGION IN SPONDYLOARTHRITIS – VALIDATION OF TWO WHOLE-BODY MRI METHODS', Annals of the Rheumatic Diseases, 80, pp. 153.2 - 154, http://dx.doi.org/10.1136/annrheumdis-2021-eular.952
,2021, 'POS0619 MODELLING OF DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES TREATED WITH ETANERCEPT ORIGINATOR OR BIOSIMILAR AS FIRST-LINE BIOLOGIC IN AN AUSTRALIAN REAL-WORLD DATASET', Annals of the Rheumatic Diseases, 80, pp. 547.1 - 547, http://dx.doi.org/10.1136/annrheumdis-2021-eular.2265
,2020, 'Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia', Clinical Rheumatology, 39, pp. 2545 - 2551, http://dx.doi.org/10.1007/s10067-020-05021-7
,2020, 'Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset', Journal of Rheumatology, 47, pp. 1174 - 1181, http://dx.doi.org/10.3899/jrheum.190535
,2020, 'Early vertebroplasty within 3 weeks of fracture for acute painful vertebral osteoporotic fractures: subgroup analysis of the VAPOUR trial and review of the literature', European Spine Journal, 29, pp. 1606 - 1613, http://dx.doi.org/10.1007/s00586-020-06362-2
,2020, 'Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patients', BMJ Evidence-Based Medicine, 25, pp. 85 - 89, http://dx.doi.org/10.1136/bmjebm-2019-111171
,2020, 'Emerging Imaging Techniques in Spondyloarthritis: Dual-Energy Computed Tomography and New MRI Sequences', Rheumatic Disease Clinics of North America, 46, pp. 287 - 296, http://dx.doi.org/10.1016/j.rdc.2020.01.010
,2020, 'Vertebroplasty has an important role in managing patients with severe pain when performed early and with appropriate technique', Internal Medicine Journal, 50, pp. 647 - 648, http://dx.doi.org/10.1111/imj.14830
,2020, 'Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS)', RMD Open, 6, http://dx.doi.org/10.1136/rmdopen-2019-001150
,2020, 'SAT0425 NOVEL COMPUTER-ASSISTED METHODOLOGY FOR QUANTITATIVE ASSESSMENT OF MRI TREATMENT RESPONSES TO APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS', Annals of the Rheumatic Diseases, 79, pp. 1166.1 - 1167, http://dx.doi.org/10.1136/annrheumdis-2020-eular.1335
,2019, 'Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)', Journal of Rheumatology, 46, pp. 1215 - 1221, http://dx.doi.org/10.3899/jrheum.181084
,2019, 'The OMERACT MRI in enthesitis initiative: Definitions of key pathologies, suggested MRI sequences, and a novel heel enthesitis scoring system', Journal of Rheumatology, 46, pp. 1232 - 1238, http://dx.doi.org/10.3899/jrheum.181093
,2019, 'Utility of magnetic resonance imaging in diagnosis and monitoring enthesitis in patients with spondyloarthritis: An OMERACT systematic literature review', Journal of Rheumatology, 46, pp. 1207 - 1214, http://dx.doi.org/10.3899/jrheum.181083
,2019, 'Validity and responsiveness of combined inflammation and combined joint damage scores based on the OMERACT rheumatoid arthritis MRI scoring system (RAMRIS)', Journal of Rheumatology, 46, pp. 1222 - 1227, http://dx.doi.org/10.3899/jrheum.181064
,2019, 'Percutaneous Vertebroplasty for Acute Painful Osteoporotic Vertebral Fractures—Benefits Shown in VAPOUR Trial Masked When Pooled With Other Clinical Trials', Journal of Bone and Mineral Research, 34, pp. 1182 - 1184, http://dx.doi.org/10.1002/jbmr.3725
,2019, 'Imaging in the Mobile Domain', Rheumatic Disease Clinics of North America, 45, pp. 291 - 302, http://dx.doi.org/10.1016/j.rdc.2019.01.002
,2019, 'Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib', RMD Open, 5, http://dx.doi.org/10.1136/rmdopen-2018-000742
,2018, 'Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population', Rheumatology and Therapy, 5, pp. 383 - 401, http://dx.doi.org/10.1007/s40744-018-0118-2
,2018, 'Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL', Internal Medicine Journal, 48, pp. 1185 - 1192, http://dx.doi.org/10.1111/imj.14028
,2018, 'A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population', International Journal of Rheumatic Diseases, 21, pp. 1581 - 1590, http://dx.doi.org/10.1111/1756-185X.13243
,2018, 'A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial', Osteoarthritis and Cartilage, 26, pp. 880 - 887, http://dx.doi.org/10.1016/j.joca.2018.02.899
,2018, 'Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: Results of the randomized, placebocontrolled PALACE 4 trial', Rheumatology (United Kingdom), 57, pp. 1253 - 1263, http://dx.doi.org/10.1093/rheumatology/key032
,2018, 'Evaluation of the effect of baseline MRI sacroiliitis and c reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: A post hoc analysis of the EMBARK study', Annals of the Rheumatic Diseases, 77, pp. 1090 - 1093, http://dx.doi.org/10.1136/annrheumdis-2017-211313
,2018, 'Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors', Clinical Rheumatology, 37, pp. 1617 - 1623, http://dx.doi.org/10.1007/s10067-018-4105-3
,